Seeking Alpha

Discovery Labs (DSCO) announces FDA approval for Surfaxin. The company anticipates that the...

Discovery Labs (DSCO) announces FDA approval for Surfaxin. The company anticipates that the treatment for respiratory illness in infants will be commercially available in the U.S. in late 2012. Shares are halted AH.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|